4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-18-063802
Chief Commercial Officer gave up 498 shares (to pay taxes)
- Chief Commercial Officer acquired 1,750 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Fair Brett Chief Commercial Officer | 2018-12-18 | Option exercise | +1,750 | 8,513 | D | ||
| Fair Brett Chief Commercial Officer | 2018-12-18 | Shares withheld for taxes | −498 | $6.30 | $3,137 | 8,015 | D |
| Derivatives | |||||||
| Fair Brett Chief Commercial Officer | 2018-12-18 | Option exercise · Restricted Stock Units | −1,750 | 1,750 | D | ||
Loading xslF345X03/doc4.xml…